The Chinese OTC Pharmaceuticals Market is Worth an Estimated US$34.89bn
Posted on: Tuesday, 12 September 2006, 00:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c41892) has announced the addition of OTC Pharmaceuticals in China 2006 to their offering.
China has a large and fast-growing pharmaceuticals industry. The estimated value of the domestic industry in China, at the end of 2005, will be in the region of RMB288.74bn (US$34.89bn), and will have grown by over 140% since 1998.
For the domestic industry in China, the problem is that, although it is one of the world's largest bulk manufacturers of raw drugs ingredients, it has yet to develop a real capability to develop its own proprietary drugs. This means that 99% of the over-the-counter drugs sold in pharmacies in China were developed by foreign companies. This means that China continues to pay a royalty to these developers, for drugs it could easily be developing for itself.
Given the huge size of the domestic market, both for OTC and prescription drugs, the value of the royalties paid must be huge - which is why foreign drugs makers are so keen to corner the market for themselves. However, the Chinese manufacturers are at last beginning to work together to develop their own patent drugs, in order to begin reaping real profits.
This report, as well as all the usual market size, share, breakdown and forecast data, includes over 100 company profiles!
This report covers the market for over-the-counter (OTC) pharmaceuticals in the People's Republic of China. The report covers the following sectors:
-- Analgesics
-- Cough, cold and allergy (hay-fever) remedies
-- Digestive remedies
-- Medicated skincare
-- Vitamins and dietary supplements
-- Other OTC healthcare
KEY REPORT FEATURES
This newly updated and greatly expanded report covers:
-- Overview of China's total non-food market, with retail sales statistics up to 2005;
-- Market size analysis of China's overall and OTC pharmaceutical market;
-- Volume & value retail market for OTC pharmaceuticals in China, including regional and sector breakdown, up to 2005;
-- Retail pricing trends of OTC pharmaceutical products by sector up to 2005;
-- Volume & value forecast total pharmaceutical market growth and OTC pharmaceuticals in China, including sector growth, up to 2010;
-- Marketing & advertising analysis;
-- Statistical analysis on pharmaceutical industry by sector, with data on major manufacturers in China;
-- Profiles of leading pharmaceutical companies in China;
-- Key contacts & trade events;
-- Overview of China's demographics and macroeconomics.
Topics Covered
-- 1 CHINA'S OTC PHARMACEUTICALS MARKET
-- 2 MARKETING & DISTRIBUTION
-- 3 CHINA'S HEALTHCARE SERVICES
-- 4 SOURCES OF SUPPLY
-- 5 SWOT ANALYSIS
-- 6 COMPANY PROFILES
-- 7 CONTACTS
-- 8 RELEVANT TRADE FAIRS & EXHIBITIONS
-- APPENDIX: MARKET BACKGROUND
The Companies Mentioned inside this report include:
- Anhui Fengyuan Pharmaceutical Co, Ltd - Astrazeneca (Wuxi) Pharmaceutical Co, Ltd - Bayer AG - Beijing Double Crane Pharmaceutical Co, Ltd - Beijing SL Pharmaceutical Co, Ltd - Beijing Tiantan Biological Products Corp Ltd - Beijing Tongrentang Co, Ltd - Chengdu Hoist Inc Ltd - Chengzhi Co, Ltd - Chiatai Qingchunbao Pharmaceutical Co, Ltd - China National Medicines Corp Ltd - Chongqing Huapont Pharmaceutical Co, Ltd - Chongqing Taiji Industry (Group) Co, Ltd - Chongqing Three Gorges Stock Group Co, Ltd - Chongqing Tongjunge Co, Ltd - Dalian Merro Pharmaceutical Co, Ltd - Guangdong Kangmei Pharmaceutical Co, Ltd - Guangxi Beisheng Pharmaceutical Co, Ltd - Guangzhou Baiyunshan Pharmaceutical Stock Co, Ltd - Guangzhou Pharmaceutical Co, Ltd - Guilin Jiqi Pharmaceutical Co, Ltd - Guizhou Yibai Pharmaceutical Co, Ltd - Hainan Haiyao Co, Ltd - Hangzhou Tianmushan Pharmaceutical Co, Ltd - Harbin Pharmaceutical Group Holding Co, Ltd - Harbin Pharmaceutical Group Sanjing Pharmaceutical Co, Ltd - Henan Joyline & Joysun Pharmaceutical Co, Ltd - Henan Lingrui Pharmaceutical Co, Ltd - Henan Topfond Pharmaceutical Co, Ltd - Hengdian Group Tospo Pharmaceutical Co, Ltd - Huadong Medicine Co, Ltd - Hualan Biological Engineering Inc - Hubei Biocause Pharmaceutical Co, Ltd - Hubei Guangji Pharmaceutical Co, Ltd - Hubei Qiangjiang Pharmaceutical Co, Ltd - Inner Mongolia Biological Pharmaceutical Factory - Jiangsu Hengrui Medicine Co, Ltd - Jiangsu Kanion Pharmaceutical Co, Ltd - Jiangsu Lianhuan Pharmaceutical Co, Ltd - Jiangsu Sihuan Bio-Engineering Co, Ltd - Jiangsu Yangzi River Pharmaceutical Group Co - Jiangxi Huiren Group Co, Ltd - Jiangxi Jiangzhong Pharmaceutical Co, Ltd - Jilin Aodong Medicine Industry Co, Ltd - Jilin Pharmaceutical Co, Ltd - Jilin Xiuzheng Pharmaceutical Group Co, Ltd - Ji'nan Guta Veterinary Pharmacy Co, Ltd - Jinling Pharmaceutical Co, Ltd - Jiuzhitang Co, Ltd - Joincare Pharmaceutical Industry Group - Kunming Pharmaceutical Corp - Livzon Pharmaceutical Group Co, Ltd - Nanjing Medical Co, Ltd - North China Pharmaceutical Group Corp - Northeast Pharmaceutical Group Co, Ltd - Qilu Pharmaceutical Factory Pingyin Branch - Qingdao Groful Pharmaceuticals Co, Ltd - Qingdao Jiante Biological Investment Co, Ltd - Rejoy Group Co, Ltd - S&P Pharmaceutical Co, Ltd - Sanjiu () Medical & Pharmaceutical Co, Ltd - Shangdong Dong-e E-jiao (Dong'e As-skin) Co, Ltd - Shandong Liuhe Animal Science Technology Park - Shandong Lukang Pharmaceutical Group Co, Ltd - Shandong Xinhua Medicine Group Co, Ltd - Shanghai Asia Pioneer Pharmaceuticals Co, Ltd - Shanghai Jiaoda Onlly Co, Ltd - Shanghai Leiyunshang Pharmaceutical Co, Ltd - Shanghai Modern Pharmaceutical Co, Ltd - Shanghai Novartis Animal Health Co, Ltd - Shanghai Number Pharmacy Co, Ltd - Shanghai Pharmaceutical Co, Ltd - Shanghai Roche Pharmaceutical Co, Ltd - Shanghai Tongren Pharmacy Industry Co, Ltd - Shanghai Worldbest Pharmaceutical Co, Ltd - Shanghai Zhongxi Pharmaceutical Co, Ltd - Shanxi Yabao Pharmaceutical Group Co, Ltd- Shenzhen Accord Pharmaeutical Co, Ltd - Shijiazhuang Pharmaceutical Group Co, Ltd - Sichuan Baoguang Pharmaceutical Technology Co, Ltd - Sichuan Dikang Pharmaceutical Co, Ltd - Sichuan Joint-wit Medica & Pharmaceutical Industry Co, Ltd - Sihuan Pharmaceutical Co, Ltd - Sino-American Shanghai Squibb Pharmaceutical Co, Ltd - Southwest Pharmaceutical Co, Ltd - Taiji Group Fuling Pharmaceutical Factory -Tianjin Jinyao Group Co, Ltd - Tianjin Pacific Holdings Group Ltd - Tianjin Tasly Pharmaceutical Co, Ltd - Tianjin Tianyao Pharmaceutical Co, Ltd - Tianjin Zhongxin Pharmaceutical Group Co, Ltd - Tibet Rhodiola Pharmaceutical Co, Ltd - Tonghua Dongbao Medicines Co, Ltd - Tonghua Goldhorse Medicine Co, Ltd - Topsun Science & Technology Co, Ltd - Tsinghua Unisplendour Guhan Bio-pharmaceutical Co, Ltd - Wuhan Jianmin Pharmaceutical Co, Ltd - Wuhan Mayinglong Pharmaceutical Co, Ltd - Wuhan Spring Biological Engineering Co, Ltd - Xi'an Janssen Pharmaceutical Co, Ltd - Xinle Yuanda Veterinary Pharmaceutical Co, Ltd - Yunnan Baiyao Group Co, Ltd - Zhangzhou Pianzihuang Pharmaceutical Co, Ltd - Zhejiang Conba Pharmaceutical Co, Ltd - Zhejiang Haizheng (Hisun) Group Co, Ltd - Zhejiang Huahai Pharmaceutical Co, Ltd - Zhejiang International Group Co, Ltd - Zhejiang Jingxin Pharmaceutical Co, Ltd - Zhejiang Medicine Co, Ltd - Zhejiang Xinheceng Co, Ltd - Zhejiang Zhenyuan Co, Ltd - Zhuzhou Qianjin Pharmaceutical Co, Ltd
For more information visit http://www.researchandmarkets.com/reports/c41892
Source: Business Wire
Related Articles
- Simcere Pharmaceutical Group Announces Agreement to Acquire 37.5% Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
- Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
- Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.'s Fourth Investor Tour of China
- Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
- Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
- Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)
- Par Pharmaceutical Returns PAR-101 Marketing Rights to Optimer Pharmaceuticals
- BioSante Pharmaceuticals Signs Bio-E-Gel(R) Marketing Agreement With Bradley Pharmaceuticals, Inc.
- China's Shanghai Pharmaceutical Group Granted Right to Produce Tamiflu
- Bausch & Lomb Completes Acquisition of Shandong Chia Tai Freda Pharmaceutical Group
User Comments (0)

RSS Feeds